RxDoctor Payments Data

Senthil Palaniappun, MD

Vascular & Interventional Radiology · Oklahoma City, OKNPI 1205082401

Payments from drug & device makers

What this record shows

This record is dominated by other: $108,583 of the $111,059 with a category attached, or 97.8%. Angiodynamics, Inc. accounts for 98.3% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $31,439, more than ten times the $40 reported in 2020. Among vascular & interventional radiology clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$111,059in general payments, 2019–2025

Across 34 payments — averaging $3266.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$109K
  • Merit Medical Systems Inc$1K
  • Biotronik Inc.$276
  • Johnson & Johnson$150
  • Organogenesis Inc.$92
  • Asahi Intecc USA, Inc.$71
  • plus $203 from 5 others

What the payments were for

  • Travel & lodging$9061%
  • Food & beverage$1,5691%
  • Other$108,58398%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$111,059 in reported general payments places this provider in the 95th percentile of 42 vascular & interventional radiology providers in Oklahoma.

See all vascular & interventional radiology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$669,095
Medicare patients
43
Services billed
1,000

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban23$18,616
ClopidogrelClopidogrel Bisulfate64$920

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →